Coree srl is an Italian company specialized in the Research and Development of food supplements, pharmaceutical products and medical devices.
Founded in 2016, the company has always been committed to the development of innovative probiotics. Thanks to the collaboration with affiliated company Hamni Pharmaceutical, Coree srl has a strong committment on R&D and has built since the beginning a very important network with main KOL.
Our history
R&D made in Italy
Coree srl has a strong committment on R&D and has established lasting collaboration with Italian institutions such as the Catholic University, the Ca’ Granda Children’s Hospital in Milan, the Gemelli Hospital in Rome, the center for research on the Microbiome AAT (Piacenza) and more recently with Istituto Mario Negri (Milan), developing many projects on microbiome and on probiotics.
Food supplement
One of the result of this activity has been the launch of a line of probiotics based on the SynterAct® technology, an European patent pending formulation. The research have shown that the blend of the 3 strains (Lacticaseibacillus rhamnosus, Bifidobacterium lactis, Bifidobacterium breve) has synergistic properties if taken with food, ideal for peadiatric usage.
The health of the gut microbiota is fundamental to the overall wellness of the body. The new brand arose from the experience of Coree, partner of the Korean pharmaceutical group Hanmi: Dx&Vx.
An innovative line of food supplements all formulated with probiotics and specific active ingredients to meet multiple needs and requirements.